DaVita HealthCare Partners

DVA

DaVita Inc. provides kidney dialysis services through a network of 2,753 outpatient dialysis centers in the United States, serving 206,900 patients, and 259 outpatient dialysis centers in 10 other countries serving 28,700 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver.In 2019, 69% of the company's revenues came from Medicare and other government-based health insurance programs. In 2019, 90% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 31% of revenues in 2019, generate all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.The company is ranked 188th on the Fortune 500.The name "DaVita" is derived from the Italian language phrase "Dare Vita", which means "giving life".

DaVita HealthCare Partners has been a target of short sellers for a while. The current short interest of 7.80% is roughly at the average of the last 12 months (9.12%).